260 related articles for article (PubMed ID: 18340495)
1. Clinicopathologic characteristics and prognosis for young gastric adenocarcinoma patients after curative resection.
Lai JF; Kim S; Li C; Oh SJ; Hyung WJ; Choi WH; Choi SH; Wang LB; Noh SH
Ann Surg Oncol; 2008 May; 15(5):1464-9. PubMed ID: 18340495
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.
Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ
J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464
[TBL] [Abstract][Full Text] [Related]
4. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage in gastric carcinoma.
Kato M; Saji S; Kawaguchi Y; Kunieda K; Sugiyama Y; Takagi Y; Hiraoka T; Kumazawa I; Adachi T
Hepatogastroenterology; 1999; 46(30):3281-6. PubMed ID: 10626202
[TBL] [Abstract][Full Text] [Related]
6. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
7. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer.
Shin SH; Jung H; Choi SH; An JY; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Ann Surg Oncol; 2009 May; 16(5):1304-9. PubMed ID: 19241107
[TBL] [Abstract][Full Text] [Related]
9. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
10. A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients.
Landry CS; Brock G; Scoggins CR; McMasters KM; Martin RC
Ann Surg Oncol; 2009 Jan; 16(1):51-60. PubMed ID: 18953609
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with pN3 stage tumors according to the TNM classification in advanced gastric cancer.
Kikuchi S; Katada N; Sakuramoto S; Koabayashi N; Shimao H; Sakakibara Y; Kakita A
Hepatogastroenterology; 2003; 50(53):1723-6. PubMed ID: 14571827
[TBL] [Abstract][Full Text] [Related]
12. Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma.
Michelassi F; Takanishi DM; Pantalone D; Hart J; Chappell R; Block GE
Surgery; 1994 Oct; 116(4):804-9; discussion 809-10. PubMed ID: 7940182
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger.
Hsieh FJ; Wang YC; Hsu JT; Liu KH; Yeh CN
J Surg Oncol; 2012 Mar; 105(3):304-9. PubMed ID: 22116742
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic characteristics and prognosis of mucinous gastric carcinoma.
Zhang M; Zhu GY; Zhang HF; Gao HY; Han XF; Xue YW
J Surg Oncol; 2010 Jul; 102(1):64-7. PubMed ID: 20578080
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
[TBL] [Abstract][Full Text] [Related]
16. Impact of lymphovascular invasion in patients with stage I gastric cancer.
Kunisaki C; Makino H; Kimura J; Takagawa R; Kosaka T; Ono HA; Akiyama H; Fukushima T; Nagahori Y; Takahashi M
Surgery; 2010 Feb; 147(2):204-11. PubMed ID: 19878963
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
18. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature.
Aurello P; D'Angelo F; Rossi S; Bellagamba R; Cicchini C; Nigri G; Ercolani G; De Angelis R; Ramacciato G
Am Surg; 2007 Apr; 73(4):359-66. PubMed ID: 17439029
[TBL] [Abstract][Full Text] [Related]
19. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China.
Deng J; Liang H; Sun D; Wang D; Pan Y
Ann Surg Oncol; 2010 May; 17(5):1259-66. PubMed ID: 20217252
[TBL] [Abstract][Full Text] [Related]
20. Biologic predictors of survival in node-negative gastric cancer.
Kooby DA; Suriawinata A; Klimstra DS; Brennan MF; Karpeh MS
Ann Surg; 2003 Jun; 237(6):828-35; discussion 835-7. PubMed ID: 12796579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
